Global Human Milk Oligosaccharides (HMOs) in Infant Formula In-Depth Monitoring and Development Analysis Report 2023

Report ID: ARS10430 | Category: Food & Beverage | Pages: 98 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3850.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Human Milk Oligosaccharides (HMOs) in Infant Formula market size in 2022 is 115240.0 million US dollars, and it is expected to be 445275.6 million US dollars by 2029, with a compound annual growth rate of 21.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Human Milk Oligosaccharides (HMOs) in Infant Formula market include ZuChem Inc. (U.S.), Elicityl SA (France), Jennewein Biotechnologie GmbH (Germany), Friesland Campina (Netherlands), and BASF SE (Germany). The share of the top 3 players in the Human Milk Oligosaccharides (HMOs) in Infant Formula market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Human Milk Oligosaccharides (HMOs) in Infant Formula market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. 2’FL accounted for XX% of Human Milk Oligosaccharides (HMOs) in Infant Formula market in 2022. 3’FL share of XX%.
Infant Formulas accounted for XX% of the Human Milk Oligosaccharides (HMOs) in Infant Formula market in 2022. Health Ingredients for Human and Animal accounts for XX%.

This Human Milk Oligosaccharides (HMOs) in Infant Formula market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Human Milk Oligosaccharides (HMOs) in Infant Formula market country level analysis
The countries covered in the Human Milk Oligosaccharides (HMOs) in Infant Formula market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Human Milk Oligosaccharides (HMOs) in Infant Formula Market Share Analysis
Human Milk Oligosaccharides (HMOs) in Infant Formula market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Human Milk Oligosaccharides (HMOs) in Infant Formula market.

Chapter Outline
   Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
   Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula market type, application,  player and country market segmentation data.
   Chapters 8-9: Segmented the global Human Milk Oligosaccharides (HMOs) in Infant Formula market by type, and application. Analyze the revenue of market segments from different perspectives.
   Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans. 
   Chapter 11: Analyzes the main companies in the Human Milk Oligosaccharides (HMOs) in Infant Formula industry, including their main businesses, products/services, revenue, gross and gross margin.
   Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
   United States
   Canada
Asia Pacific
   China
   Japan
   Korea
   Southeast Asia
   India
   Australia
Europe
   Germany
   France
   UK
   Italy
   Russia
   Spain
   Nordic
South America
   Brazil
   Argentina
   Colombia
   Mexico
Middle East & Africa
   Egypt
   South Africa
   Israel
   Turkey
   GCC Countries

Player list
	   ZuChem Inc. (U.S.)
	   Elicityl SA (France)
	   Jennewein Biotechnologie GmbH (Germany)
	   Friesland Campina (Netherlands)
	   BASF SE (Germany)
	   Gnubiotics (Switzerland)
	   Inbiose NV (Belgium)
	   Glycom A/S (Denmark)
	   Glycosyn LLC (U.S.)
	   Nestle S.A. (Switzerland)
	   DuPont (U.S.)
	   DSM (Netherlands)
	   Chr. Hansen A/S (Denmark)
	   Biosynth Carbosynth (Switzerland)
	   Flavors & Fragrances Inc. (U.S.)
	   Abbott (U.S.)
	   Medolac (U.S.)

Types list
	   2’FL
	   3’FL
	   3’SL
	   6’SL

Application list
	   Infant Formulas
	   Health Ingredients for Human and Animal
	   Food and Beverages
	   Food Supplements

Table of Content

1 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Introduction and Overview
1.1 Human Milk Oligosaccharides (HMOs) in Infant Formula Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
2.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Growth Trends Analysis by Regions
2.2.1 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size by Regions: 2018 VS 2023 VS 2029
2.2.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Historic Market Size by Regions (2018-2023)
2.2.3 Human Milk Oligosaccharides (HMOs) in Infant Formula Forecasted Market Size by Regions (2023-2029)
2.2.4 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
2.2.5 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
2.2.6 Asia-Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
2.2.7 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
2.2.8 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Market Size & Forecast (2018-2029)
3 North America
3.1 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries
3.1.1 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries (2018-2029)
3.2 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Players
3.3 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Types
3.4 North America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries
4.1.1 Asia Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries (2018-2029)
4.2 Asia Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Players
4.3 Asia Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Types
4.4 Asia Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries
5.1.1 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries (2018-2029)
5.2 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Players
5.3 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Types
5.4 Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries
6.1.1 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries (2018-2029)
6.2 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Players
6.3 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Types
6.4 Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries
7.1.1 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Countries (2018-2029)
7.2 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Players
7.3 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Types
7.4 Middle East & Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Historical and Forecast Market Analysis by Type
8.1 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue and Market Share by Type
8.2 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market Forecast by Type (2023-2029)
9 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Historical and Forecast Market Analysis by Application
9.1 Global Human Milk Oligosaccharides (HMOs) in Infant Formula Revenue Market Share by Application (2018-2023)
9.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Forecast by Application (2023-2029)
10 Human Milk Oligosaccharides (HMOs) in Infant Formula Industry Dynamic Analysis
10.1 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Trends Analysis
10.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Drivers Analysis
10.3 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Challenges Analysis
10.4 Human Milk Oligosaccharides (HMOs) in Infant Formula Market Restraints Analysis
10.5 Human Milk Oligosaccharides (HMOs) in Infant Formula Industry Mergers & Acquisitions
10.6 Human Milk Oligosaccharides (HMOs) in Infant Formula Industry New Entrants and Expansion Plans
11 Players Profiles
11.1  ZuChem Inc. (U.S.)
11.1.1 ZuChem Inc. (U.S.) Company Profile
11.1.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.1.3 ZuChem Inc. (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.1.4 ZuChem Inc. (U.S.) Business Overview
11.2  Elicityl SA (France)
11.2.1 Elicityl SA (France) Company Profile
11.2.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.2.3 Elicityl SA (France) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.2.4 Elicityl SA (France) Business Overview
11.3  Jennewein Biotechnologie GmbH (Germany)
11.3.1 Jennewein Biotechnologie GmbH (Germany) Company Profile
11.3.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.3.3 Jennewein Biotechnologie GmbH (Germany) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.3.4 Jennewein Biotechnologie GmbH (Germany) Business Overview
11.4  Friesland Campina (Netherlands)
11.4.1 Friesland Campina (Netherlands) Company Profile
11.4.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.4.3 Friesland Campina (Netherlands) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.4.4 Friesland Campina (Netherlands) Business Overview
11.5  BASF SE (Germany)
11.5.1 BASF SE (Germany) Company Profile
11.5.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.5.3 BASF SE (Germany) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.5.4 BASF SE (Germany) Business Overview
11.6  Gnubiotics (Switzerland)
11.6.1 Gnubiotics (Switzerland) Company Profile
11.6.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.6.3 Gnubiotics (Switzerland) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.6.4 Gnubiotics (Switzerland) Business Overview
11.7  Inbiose NV (Belgium)
11.7.1 Inbiose NV (Belgium) Company Profile
11.7.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.7.3 Inbiose NV (Belgium) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.7.4 Inbiose NV (Belgium) Business Overview
11.8  Glycom A/S (Denmark)
11.8.1 Glycom A/S (Denmark) Company Profile
11.8.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.8.3 Glycom A/S (Denmark) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.8.4 Glycom A/S (Denmark) Business Overview
11.9  Glycosyn LLC (U.S.)
11.9.1 Glycosyn LLC (U.S.) Company Profile
11.9.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.9.3 Glycosyn LLC (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.9.4 Glycosyn LLC (U.S.) Business Overview
11.10  Nestle S.A. (Switzerland)
11.10.1 Nestle S.A. (Switzerland) Company Profile
11.10.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.10.3 Nestle S.A. (Switzerland) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.10.4 Nestle S.A. (Switzerland) Business Overview
11.11  DuPont (U.S.)
11.11.1 DuPont (U.S.) Company Profile
11.11.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.11.3 DuPont (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.11.4 DuPont (U.S.) Business Overview
11.12  DSM (Netherlands)
11.12.1 DSM (Netherlands) Company Profile
11.12.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.12.3 DSM (Netherlands) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.12.4 DSM (Netherlands) Business Overview
11.13  Chr. Hansen A/S (Denmark)
11.13.1 Chr. Hansen A/S (Denmark) Company Profile
11.13.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.13.3 Chr. Hansen A/S (Denmark) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.13.4 Chr. Hansen A/S (Denmark) Business Overview
11.14  Biosynth Carbosynth (Switzerland)
11.14.1 Biosynth Carbosynth (Switzerland) Company Profile
11.14.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.14.3 Biosynth Carbosynth (Switzerland) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.14.4 Biosynth Carbosynth (Switzerland) Business Overview
11.15  Flavors & Fragrances Inc. (U.S.)
11.15.1 Flavors & Fragrances Inc. (U.S.) Company Profile
11.15.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.15.3 Flavors & Fragrances Inc. (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.15.4 Flavors & Fragrances Inc. (U.S.) Business Overview
11.16  Abbott (U.S.)
11.16.1 Abbott (U.S.) Company Profile
11.16.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.16.3 Abbott (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.16.4 Abbott (U.S.) Business Overview
11.17  Medolac (U.S.)
11.17.1 Medolac (U.S.) Company Profile
11.17.2 Human Milk Oligosaccharides (HMOs) in Infant Formula Product Overview
11.17.3 Medolac (U.S.) Human Milk Oligosaccharides (HMOs) in Infant Formula Market Performance (2018-2023)
11.17.4 Medolac (U.S.) Business Overview
12 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Human Milk Oligosaccharides (HMOs) in Infant Formula In-Depth Monitoring and Development Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?